Autopsy report · NCT02768220

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

“no funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Northwell Health

Sponsor type

University, hospital or other

Conditions

SGLT-2 Inhibitors; Advanced Glycation End Products; Diabetes

Interventions

empagliflozin; linagliptin

Participants

0

Trials that died the same way

• Prehabilitation in Patients on a Waiting List for a Transplant
  “No funded” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.